Resources, guidance and updates from the GDP community.
2025 Conferences
Repercussions of the Windsor Framework by Natasha Long, Fusion Pharma LimitedDelegates at the 2025 UK GDP Association CIC Annual Conference heard from a wide range of industry specialists from across the pharmaceutical, and healthcare sectors. Among...
2025 Conferences
Regulatory Agencies in UK and Ireland: Spot the Difference At the 2025 UK GDP Association Annual Conference, one session that drew strong interest from Responsible Persons, compliance leads, and distribution professionals was “MHRA and HPRA – Spot...
2025 Conferences
The 2025 UK GDP Association Annual Conference - were you there? The 2025 UK GDP Association Annual Conference brought together professionals at the heart of Good Distribution Practice (GDP), regulatory compliance, quality assurance and...
2025 Conferences
Medicine Shortages and Banned Exports by Graham Stewart, DHSC At the 2025 UK GDP Association CIC Annual Conference, attendees heard from a wide range of experts working across regulation, supply chain management and pharmaceutical quality. Each...
2025 Conferences
Understanding ARMPs IMPS and Clinical Trials by Steve Mannering (Thermo Fisher Scientific)Our 2025 UK GDP Association Conference brought together some of the most respected leaders shaping the future of pharmaceutical quality and compliance. In this...
2025 Conferences
UK Medical Cannabis Progress, and the challenges to come The second speaker session on day one of the 2025 UK GDP Association Annual Conference came from Nik Sanghara, Director of Canna Strategy Ltd, who provided delegates with a thorough,...
2025 Conferences
In the complex and highly regulated world of pharmaceutical distribution, ensuring the integrity of the supply chain is paramount. Every link, from the initial sourcing of medicinal products to their final delivery, must be robust, reliable, and...
Join the UK GDP Association to access exclusive member-only articles, early event access, and professional development resources.